Colorado BioScience Association Features Replidyne, iBalance Medical, BioWest 2005 and the Recent Bioscience Forum in the Fall 2005 Edition of The CBSA FOCUS
Colorado BioScience Association (CBSA) has published the third issue of its quarterly newsletter, “The CBSA FOCUS.” Featured articles in the Fall 2005 publication cover BioWest 2005, Coming Events, Executive Report, iBalance Medical, Regulatory Update, Replidyne, Bioscience Forum, and News Briefs. The newsletter helps further share the many success stories and highlights of Colorado’s medical device and biotechnology industries.
Denver, CO, October 28, 2005 --(PR.com)-- The third issue of “The CBSA FOCUS,” the Colorado BioScience Association’s quarterly newsletter is now published. The announcement is made by Denise Brown, CBSA executive director, who says the Association’s current newsletter features articles on both Replidyne and iBalance Medical – Colorado biotech companies that have both recently announced major funding achievements. Replidyne closed one of Colorado’s largest 2005 private financing deals in September for more than $62 million in newly secured funding. iBalance Medical recently closed on an initial $4.8 million of an $8.24 million commitment in first-round venture financing.
In addition, the Fall FOCUS previews BioWest 2005 and recaps the successful Bioscience Forum attended by close to 300 in August. Other topics include coming events, executive report, regulatory update on navigating the pre-market submission process, and news briefs. Here’s a sampling of the feature articles and links to the full articles and PDF of the newsletter:
“Replidyne Makes Big Impression: Raising Money and Eyebrows” -- After closing one of Colorado's largest 2005 private financing deals in September -- more than $62 million in newly secured funding -- Replidyne is quickly becoming a major player in the state's bioscience community. The Louisville biopharmaceutical company has raised over $121 million and lots of eyebrows since it was founded in 2002. You can read the FOCUS article about Replidyne at http://expert411.com/_wsn/page8.html.
“iBalance Medical: Aligning Itself For Success” -- Founded in 2004 by a Massachusetts transplant, Boulder start-up iBalance Medical recently closed on an initial $4.8 million of an $8.24 million commitment in first-round venture financing. The company is now ready to move into high gear on its new surgical product and procedure for knee reconstruction that focuses uniquely on treating malalignment of the joint, delaying or eliminating the need for total knee replacement surgery for many patients. Read the FOCUS article about iBalance Medical at http://publicrelationsnewsroom.com/_wsn/page5.html.
“BioWest 2005” -- On November 8 and 9, Colorado will highlight its status as the center of the Rocky Mountain region's bioscience industry as hundreds of professionals converge at the Denver Convention Center for the BioWest 2005 conference. The only event of its kind in the region, it is expected to bring together 700 medical device and biotech players from Colorado, New Mexico, Utah, Montana, Idaho and Wyoming. “Leaders Convene to Support Colorado Bioscience Industry” -- On August 9, nearly 300 people attended an educational event hosted by the Colorado BioScience Association (CBSA) and the Biotechnology Industry Organization (BIO) to learn about the bioscience industry in Colorado. The forum, held at the Fitzsimons research complex, brought together federal and state lawmakers, leading life science executives, university officials, patient group representatives and news media. You can read the FOCUS articles about BioWest 2005 and the Bioscience Forum at http://denverprnewsroom.com/_wsn/page20.html.
A pdf of the full first issue of FOCUS is found at this link:
http://www.pr.com/upload/presskit_1811_1129935970.pdf.
Links are also available to features included in both the Spring 2005 and Summer 2005 issues of “The CBSA FOCUS” newsletter on these topics:
1) Bioscience Execs Upbeat: New Survey Shows Increase In New Product Development -- http://www.pr.com/upload/presskit_1811_1121365070.pdf
2) McKinley Medical Carves Out a New Niche in Pain Management -- http://www.pr.com/upload/presskit_1811_1121366349.pdf
3) Colorado’s Triple Threat: Dr. Michael R. Bristow Clinician, Researcher and Entrepreneur -- http://www.pr.com/upload/presskit_1811_1121365733.pdf
4) Referendums C and D: Critical to Colorado’s Bioscience Industry – http://www.pr.com/upload/presskit_1811_1129928363.pdf
5) The Executive Team At A Company Called PR Pharmaceuticals (PRP) Has A Knack For Making The Right Moves – http://www.pr.com/upload/presskit_1811_1129935068.pdf
6) William W. Cimino, Ph.D. -- From Aerospace Engineer To Medical Technology Entrepreneur, Sound Surgical's Founder Is Ready For Take-Off -- http://www.pr.com/upload/presskit_1811_1129928482.pdf
The CBSA FOCUS newsletter is edited, written and produced by the Sage Public Relations Group (http://www.sagepublicrelations.com) in collaboration with Griff/SMC (http://www.griffsmc.com). Design and production is by New Moon Communications. For editorial comments and content ideas contact Jon Pushkin, Editor, 303-733-3441; jon@pushkinpr.com (http://www.pushkinpr.com).
About Colorado BioScience Association
Colorado BioScience Association is a not-for-profit corporation providing services and support for Colorado’s growing biosciences industry. Colorado is carrying out an aggressive plan to grow the state’s bioscience industry into one of the country’s premier bioscience clusters. CBSA currently enjoys the support of 304 member organizations representing both bioscience companies and companies providing key services to the bioscience industry and research institutions in Colorado. The association’s main office is located in the Advance Colorado Center, 1625 Broadway, Suite 950, in Denver, plus satellite offices are maintained in the Fitzsimons Bioscience Park and at the Fort Collins Technology Incubator. A Colorado Springs satellite office is planned for the future. You can learn more about CBSA at http://www.cobioscience.com.
###
Contacts:
Denise Brown, Executive Director, Colorado BioScience Association, 303.592.4073, E-mail: dbrown@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations, 303.984.9801 or 303.669.3558, E-mail: maggie@absolutelypr.com
In addition, the Fall FOCUS previews BioWest 2005 and recaps the successful Bioscience Forum attended by close to 300 in August. Other topics include coming events, executive report, regulatory update on navigating the pre-market submission process, and news briefs. Here’s a sampling of the feature articles and links to the full articles and PDF of the newsletter:
“Replidyne Makes Big Impression: Raising Money and Eyebrows” -- After closing one of Colorado's largest 2005 private financing deals in September -- more than $62 million in newly secured funding -- Replidyne is quickly becoming a major player in the state's bioscience community. The Louisville biopharmaceutical company has raised over $121 million and lots of eyebrows since it was founded in 2002. You can read the FOCUS article about Replidyne at http://expert411.com/_wsn/page8.html.
“iBalance Medical: Aligning Itself For Success” -- Founded in 2004 by a Massachusetts transplant, Boulder start-up iBalance Medical recently closed on an initial $4.8 million of an $8.24 million commitment in first-round venture financing. The company is now ready to move into high gear on its new surgical product and procedure for knee reconstruction that focuses uniquely on treating malalignment of the joint, delaying or eliminating the need for total knee replacement surgery for many patients. Read the FOCUS article about iBalance Medical at http://publicrelationsnewsroom.com/_wsn/page5.html.
“BioWest 2005” -- On November 8 and 9, Colorado will highlight its status as the center of the Rocky Mountain region's bioscience industry as hundreds of professionals converge at the Denver Convention Center for the BioWest 2005 conference. The only event of its kind in the region, it is expected to bring together 700 medical device and biotech players from Colorado, New Mexico, Utah, Montana, Idaho and Wyoming. “Leaders Convene to Support Colorado Bioscience Industry” -- On August 9, nearly 300 people attended an educational event hosted by the Colorado BioScience Association (CBSA) and the Biotechnology Industry Organization (BIO) to learn about the bioscience industry in Colorado. The forum, held at the Fitzsimons research complex, brought together federal and state lawmakers, leading life science executives, university officials, patient group representatives and news media. You can read the FOCUS articles about BioWest 2005 and the Bioscience Forum at http://denverprnewsroom.com/_wsn/page20.html.
A pdf of the full first issue of FOCUS is found at this link:
http://www.pr.com/upload/presskit_1811_1129935970.pdf.
Links are also available to features included in both the Spring 2005 and Summer 2005 issues of “The CBSA FOCUS” newsletter on these topics:
1) Bioscience Execs Upbeat: New Survey Shows Increase In New Product Development -- http://www.pr.com/upload/presskit_1811_1121365070.pdf
2) McKinley Medical Carves Out a New Niche in Pain Management -- http://www.pr.com/upload/presskit_1811_1121366349.pdf
3) Colorado’s Triple Threat: Dr. Michael R. Bristow Clinician, Researcher and Entrepreneur -- http://www.pr.com/upload/presskit_1811_1121365733.pdf
4) Referendums C and D: Critical to Colorado’s Bioscience Industry – http://www.pr.com/upload/presskit_1811_1129928363.pdf
5) The Executive Team At A Company Called PR Pharmaceuticals (PRP) Has A Knack For Making The Right Moves – http://www.pr.com/upload/presskit_1811_1129935068.pdf
6) William W. Cimino, Ph.D. -- From Aerospace Engineer To Medical Technology Entrepreneur, Sound Surgical's Founder Is Ready For Take-Off -- http://www.pr.com/upload/presskit_1811_1129928482.pdf
The CBSA FOCUS newsletter is edited, written and produced by the Sage Public Relations Group (http://www.sagepublicrelations.com) in collaboration with Griff/SMC (http://www.griffsmc.com). Design and production is by New Moon Communications. For editorial comments and content ideas contact Jon Pushkin, Editor, 303-733-3441; jon@pushkinpr.com (http://www.pushkinpr.com).
About Colorado BioScience Association
Colorado BioScience Association is a not-for-profit corporation providing services and support for Colorado’s growing biosciences industry. Colorado is carrying out an aggressive plan to grow the state’s bioscience industry into one of the country’s premier bioscience clusters. CBSA currently enjoys the support of 304 member organizations representing both bioscience companies and companies providing key services to the bioscience industry and research institutions in Colorado. The association’s main office is located in the Advance Colorado Center, 1625 Broadway, Suite 950, in Denver, plus satellite offices are maintained in the Fitzsimons Bioscience Park and at the Fort Collins Technology Incubator. A Colorado Springs satellite office is planned for the future. You can learn more about CBSA at http://www.cobioscience.com.
###
Contacts:
Denise Brown, Executive Director, Colorado BioScience Association, 303.592.4073, E-mail: dbrown@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations, 303.984.9801 or 303.669.3558, E-mail: maggie@absolutelypr.com
Contact
Colorado BioScience Association
Maggie Holben
303-984-9801
http://www.cobioscience.com
Maggie Holben
303-984-9801
http://www.cobioscience.com
Contact
Categories